Biomarin Pharmaceutical Inc. earnings dates,Biomarin Pharmaceutical Inc. earnings estimates

Announced

Period

Co. Guidance

EPS

Rev

Year Ago EPS

Actual EPS

Time

10/24/13

Q3 13

$ -0.04

$ -0.38

After Market Close

07/25/13

Q2 13

$ -0.27

$ -0.16

After market close

04/25/13

1Q13

$ -0.21

$ -0.31

Time not supplied

02/21/13

Q4 12

$ -0.23

$ -0.43

Time not supplied

10/25/12

Q3 12

$ -0.16

$ -0.04

After Market Close

08/01/12

Q2 12

$ -0.05

$ -0.27

After Market Close

04/26/12

Q1 12

$ -0.04

$ -0.21

Time not Supplied

02/16/12

Q4 11

$ -0.11

$ -0.23

After Market Close

10/27/11

Q3 11

$ 1.68

$ -0.16

After Market Close

07/28/11

Q2 11

$ -0.01

$ -0.05

Time not specified

04/28/11

Q1 11

$ 0.01

$ -0.04

Time Not Supplied

02/17/11

Q4 10

$ 0.05

$ 0.10

Time Not Supplied

10/28/10

Q3 10

$ 0.06

Time not Specified

08/02/10

Q2 10

$ 0.01

$ 0.08

After Market Close

04/29/10

Q1 10

$ -0.13

$ 0.09

Time Not Supplied

02/23/10

Q4 09

$ 0.21

$ 0.05

After Market Close

10/28/09

Q3 09

0.01

0.06

After Market Close

04/30/09

Q1 09

0.0200

Time Not Supplied

02/18/09

0.0300

0.2700

N/A

04/29/08

-0.1000

0.0000

02/26/08

Q4&FY07

-0.1100

0.0000

11/01/07

-0.0800

0.0000

05/02/07

-0.1300

0.0000

02/20/07

Q4&FY06

-0.2000

0.0000

11/01/06

-0.2100

0.0000

After Close

Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

View More Videos

News for biomarin pharmaceutical inc.

BioMarin Appoints Ian Clark As Board Chair April 22, 2026 01:33 ET
FDA Roundup: First-Line Hernexeos, Weekly Yuviwel, Expanded Palynziq & Sogroya Indications March 06, 2026 05:20 ET
FDA Expands BioMarin's PALYNZIQ Approval To Include Pediatric PKU Patients Ages 12 And Up February 27, 2026 22:11 ET
BioMarin Pharmaceutical Posts Q4 Loss February 23, 2026 16:59 ET
Biomarin Pharmaceutical Q4 25 Earnings Conference Call At 4:30 PM ET February 23, 2026 06:01 ET
BioMarin To Raise $850 Mln In Sr. Notes To Fund Amicus Acquisition January 26, 2026 08:10 ET
BioMarin Stock Surges Nearly 20% After $4.8 Bln Amicus Acquisition News December 19, 2025 15:48 ET
BioMarin To Acquire Amicus Therapeutics For Around $4.8 Bln December 19, 2025 08:13 ET
BioMarin: FDA Accepts For Priority Review PALYNZIQ SBLA To Expand Use To Adolescents Aged 12-17 October 29, 2025 09:20 ET
Biomarin Pharmaceutical Posts Q3 Loss October 27, 2025 16:34 ET

Slide Shows

biomarin pharmaceutical inc. Earnings dates

Colgate-Palmolive Q1 Profit Down, Backs FY26 Earnings, Sales Growth View; Stock Up

Humana Cuts FY26 EPS View, Backs Adj. Earnings Forecast After Weak Q1 Profit; Stock Drops

GM Q1 Results Down, Cuts FY26 Reported Earnings View, Lifts Adj. EPS Outlook

UPS Q1 Results Down, Confirms FY26 View; Stock Drops

Business

Industry News

Corp. Calendars

Earnings Calendar

FDA Calendars

Ratings Changes

Economy

Cryptocurrency

Markets

Politics

Forex

Health

Slide Shows

Entertainment

Music news

Content Licensing

Premium Services

More

biomarin pharmaceutical inc. Earnings dates

Colgate-Palmolive Q1 Profit Down, Backs FY26 Earnings, Sales Growth View; Stock Up

Humana Cuts FY26 EPS View, Backs Adj. Earnings Forecast After Weak Q1 Profit; Stock Drops

GM Q1 Results Down, Cuts FY26 Reported Earnings View, Lifts Adj. EPS Outlook

UPS Q1 Results Down, Confirms FY26 View; Stock Drops